$1.770
+0.084 (+4.73%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ABOS Prediction & Forecast by Similar Chart Analysis
Alphio's ABOS stock price prediction model matches the current Acumen Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.82 (+2.82%). The 1-week path is $1.81 (+2.11%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Acumen Pharmaceuticals Inc Stock?
Acumen Pharmaceuticals Inc is not a good buy right now due to its current price of $1.69, a very low RSI of 18.698 indicating oversold conditions, and a significant 5-day price drop of 21.03%. The company continues to report substantial net losses, with Q2 2026 showing a loss of $32.72 million, which raises concerns about its financial stability. Although there is potential upside as indicated by the analyst price target of $5, the immediate risks outweigh this potential reward.
ABOS stock price ended at $1.77 on Monday, after rising +4.73%
Acumen Pharmaceuticals Inc (ABOS) last closed at $1.77, gaining +4.73%. These facts feed the 1-day and 1-week ABOS price prediction above.
Forecast Drivers
Acumen Pharmaceuticals Inc (ABOS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ABOS, ranked by similarity.
Seasonality analysis for ABOS
Historically the probability of a positive October return for ABOS is 43.33%. March offers the highest probability of a positive month at 52.38%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ABOS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $1.66 | $1.71 | $2.00 | -3.41% |
| Nov 2026 | $1.17 | $1.41 | $1.48 | -20.59% |
| Dec 2026 | $1.39 | $1.52 | $1.62 | -14.25% |
In 2026, Acumen Pharmaceuticals Inc (ABOS) is projected to range from $1.17 to $2.00.
Acumen Pharmaceuticals Inc 2026 monthly forecast
In Oct 2026, Acumen Pharmaceuticals Inc is projected to average $1.71, with a low of $1.66 and high of $2.00.
In Nov 2026, Acumen Pharmaceuticals Inc is projected to average $1.41, with a low of $1.17 and high of $1.48.
In Dec 2026, Acumen Pharmaceuticals Inc is projected to average $1.52, with a low of $1.39 and high of $1.62.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.